Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

TGF-beta receptor type-1 inhibitors discovered at Theravance Biopharma

Oct. 28, 2021

PDGFRA overexpression in prenatal OPCs results in CNS hypomyelination

Oct. 28, 2021

Study casts light on DNA damage in esophageal cancer

Oct. 27, 2021

Diverse Biotech's DBT-12733 shows efficacy against glioblastoma tumor cells

Oct. 27, 2021

New TYK2 inhibitors synthesized at Eternity Bioscience

Oct. 27, 2021

New tyrosine-protein kinase CSK inhibitors identified at Plexxikon

Oct. 27, 2021

AstraZeneca compound shows activity against triple-mutant EGFR

Oct. 26, 2021

Kinsensus Limited describes new MERTK/AXL inhibitors

Oct. 26, 2021

The gut microbiota affects CRPC growth by contributing to androgen metabolism

Oct. 26, 2021

Therapeutic profiling unveils three functional subtypes of cancer-associated fibroblasts in NSCLC

Oct. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.